Carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in very platinum-sensitive ovarian cancer patients: Results from a subset analysis of the CALYPSO phase III trial

Mahner Sven; Meier Werner; du Bois Andreas; Brown Chris; Lorusso Domenica; DellAnna Tiziana; Cretin Jacques; Havsteen Hanne; Bessette Paul; Zeimet Alain G.; Vergote Ignace; Vasey Paul; Pujade-Lauraine Eric; Gladieff Laurence; Ferrero Annamaria

首页> 外文期刊>European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) >Carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in very platinum-sensitive ovarian cancer patients: Results from a subset analysis of the CALYPSO phase III trial

【24h】

Carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in very platinum-sensitive ovarian cancer patients: Results from a subset analysis of the CALYPSO phase III trial

机译：卡铂和聚乙二醇脂质体阿霉素与卡铂和紫杉醇对高度铂敏感的卵巢癌患者的比较：来自CALYPSO III期试验的子集分析结果

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Aim: To perform a subset analysis of patients with very platinum-sensitive recurrent ovarian cancer (ROC) enrolled in the phase III CALYPSO trial.

机译：目的：对参与III期CALYPSO试验的对铂类非常敏感的复发性卵巢癌（ROC）患者进行亚组分析。

著录项

来源
《European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)》 |2015年第3期|共7页
作者
Mahner Sven; Meier Werner; du Bois Andreas; Brown Chris; Lorusso Domenica; DellAnna Tiziana; Cretin Jacques; Havsteen Hanne; Bessette Paul; Zeimet Alain G.; Vergote Ignace; Vasey Paul; Pujade-Lauraine Eric; Gladieff Laurence; Ferrero Annamaria;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词
Pegylated liposomal doxorubicin; Carboplatin; Paclitaxel; Very platinum-sensitive; Ovarian cancer; CALYPSO;

机译：聚乙二醇脂质体阿霉素;卡铂;紫杉醇;对铂敏感;卵巢癌;CALYPSO;

相似文献

外文文献
中文文献
专利

1. Carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in very platinum-sensitive ovarian cancer patients: Results from a subset analysis of the CALYPSO phase III trial [J] . Mahner Sven, Meier Werner, du Bois Andreas, European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) . 2015,第3期

机译：卡铂和聚乙二醇脂质体阿霉素与卡铂和紫杉醇对高度铂敏感的卵巢癌患者的比较：来自CALYPSO III期试验的子集分析结果
2. Carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in partially platinum-sensitive ovariann cancer patients: results from a subset analysis of the CALYPSO phase III trial [J] . S. Mahner Annals of Oncology . 2012,第5期

机译：卡铂和聚乙二醇脂质体阿霉素与部分铂敏感的卵巢癌患者的卡铂和紫杉醇：CALYPSO III期试验的子集分析结果
3. Final overall survival results of phase III GCIG CALYPSO trial of pegylated liposomal doxorubicin and carboplatin vs paclitaxel and carboplatin in platinum-sensitive ovarian cancer patients [J] . U Wagner, C Marth, R Largillier, British Journal of Cancer . 2012,第4期

机译：聚乙二醇化脂质体阿霉素和卡铂与紫杉醇和卡铂在铂敏感型卵巢癌患者中进行的III期GCIG CALYPSO试验的最终总体生存结果
4. PHASE III COMPARISON OF CARBOPLATIN VERSUS CARBOPLATIN AND DOXORUBICIN FOR THE ADJUVANT TREATMENT OF APPENDICULAR OSTEOSARCOMA: INTERIM ANALYSIS [C] . Katherine Skorupski, Justin Uhl, Stephen Shaw, Annual Conference of the Veterinary Cancer Society . 2009

机译：Carboplatin与Carboplatin和多柔比星的相位III比较，用于辅助骨肉瘤的佐剂治疗：临时分析
5. Final overall survival results of phase III GCIG CALYPSO trial of pegylated liposomal doxorubicin and carboplatin vs paclitaxel and carboplatin in platinum-sensitive ovarian cancer patients [O] . U Wagner, C Marth, R Largillier, 2012

机译：聚乙二醇化脂质体阿霉素和卡铂与紫杉醇和卡铂在铂敏感型卵巢癌患者中进行的III期GCIG CALYPSO试验的最终总体生存结果
6. Final overall survival results of phase III GCIG CALYPSO trial of pegylated liposomal doxorubicin and carboplatin vs paclitaxel and carboplatin in platinum-sensitive ovarian cancer patients [O] . Wagner, U., Marth, C., Gebski, V., 2012

机译：聚乙二醇化脂质体阿霉素和卡铂与紫杉醇和卡铂在铂敏感型卵巢癌患者中进行的III期GCIG CALYPSO试验的最终总体生存结果

Carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in very platinum-sensitive ovarian cancer patients: Results from a subset analysis of the CALYPSO phase III trial

摘要

著录项

相似文献

相关主题

期刊订阅